What diltiazem dose is equivalent to 2.5 mg amlodipine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dose Equivalence Between Diltiazem and Amlodipine

There is no established pharmacological dose equivalence between diltiazem and amlodipine 2.5 mg, as these are different classes of calcium channel blockers with distinct mechanisms, pharmacokinetics, and clinical effects that cannot be directly converted.

Why Direct Conversion Is Not Possible

Amlodipine (a dihydropyridine) and diltiazem (a non-dihydropyridine) belong to different calcium channel blocker subclasses with fundamentally different properties 1:

  • Amlodipine acts primarily on peripheral vascular smooth muscle with minimal cardiac effects 2
  • Diltiazem has significant effects on both cardiac conduction (AV node) and vascular smooth muscle 1
  • Heart rate effects differ: Diltiazem causes bradycardia while amlodipine typically does not affect heart rate 1, 3

Clinical Context Matters

The choice between these agents should be based on clinical indication rather than dose equivalence 1:

For Hypertension

  • Amlodipine starting dose: 2.5-5 mg once daily 1
  • Diltiazem ER starting dose: 120-180 mg once daily 1
  • Studies show amlodipine produces greater blood pressure reduction than diltiazem at standard doses 3, 4

For Rate Control (SVT/Atrial Fibrillation)

  • Diltiazem is preferred due to AV nodal blocking properties 1
  • Amlodipine is ineffective for rate control and should not be used 1

For Pulmonary Hypertension (in vasoreactive patients)

  • Amlodipine: Start 2.5 mg daily, titrate up to 20 mg daily 1
  • Diltiazem: Start 60 mg TID, titrate to 240-720 mg daily 1
  • Selection based on baseline heart rate: bradycardia favors amlodipine, tachycardia favors diltiazem 1

Comparative Efficacy Data

Research comparing these agents shows they are not interchangeable 5, 6, 7, 3:

  • In hypertension trials, amlodipine 5-10 mg produced significantly greater systolic BP reduction than diltiazem 180-360 mg 3, 4
  • In angina studies, amlodipine 5-10 mg once daily was comparable to diltiazem 180 mg/day in divided doses 5, 6, 7
  • Amlodipine causes more peripheral edema; diltiazem causes more bradycardia 5, 6, 7

Practical Switching Approach

If switching from amlodipine 2.5 mg to diltiazem 1:

  1. Determine the indication: Hypertension, angina, or rate control
  2. For hypertension/angina: Start diltiazem ER 120 mg once daily and titrate based on response (not as a direct conversion)
  3. For rate control needs: Diltiazem is appropriate; amlodipine is not
  4. Monitor closely: Different side effect profiles require reassessment after switching

Critical Contraindications to Consider

Diltiazem should NOT be used if 1:

  • AV block greater than first degree without pacemaker
  • Decompensated systolic heart failure or severe LV dysfunction
  • Sick sinus syndrome without pacemaker
  • Concurrent use with beta-blockers (increased bradycardia/heart block risk)

Amlodipine can be used in these situations but avoid in decompensated heart failure 1

Related Questions

Is it safe to take amlodipine (calcium channel blocker) and diltiazem (calcium channel blocker) together?
What is the equivalent dose of amlodipine for a patient taking diltiazem 240mg?
Can diltiazem and amlodipine be co-administered?
Can amlodipine and diltiazem be combined for treating palpitations?
Can a patient with a history of cardiovascular disease, over 65 years old, with potential comorbidities such as kidney or liver disease, take amlodipine and diltiazem (calcium channel blockers) together?
What is the appropriate levetiracetam (Keppra) dosage in mg per kilogram for treating epilepsy?
Can you develop a research proposal for a prospective observational cohort study assessing how adherence to core clinical quality indicators—dialysis adequacy (single‑pool Kt/V ≥1.4), anemia management (hemoglobin 11‑12 g/dL with erythropoiesis‑stimulating agents), vascular access type (≥80 % arteriovenous fistulas, ≤5 % catheter use), serum albumin (≥4.0 g/dL), phosphorus (3.5‑5.5 mg/dL), bicarbonate (22‑26 mmol/L), and missed treatment rate (≤5 %)—affects outcomes such as hospitalization, mortality, and health‑related quality of life in adult (≥18 years) in‑center hemodialysis patients at a hospital?
Can you provide psychoeducation on the appropriate use, dosing, contraindications, and safety considerations for suvorexant in adults with insomnia?
Summarize ileus.
What is the recommended treatment regimen for chronic sinusitis?
What is parasympathetic tone, how is it assessed, and how can it be increased or decreased clinically?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.